Spotlight
Areas of Expertise (10)
Business
Operations Management
Supply Chain Management
Pharmaceutical Industries
Pharmaceutical Drug Pricing
Healthcare Industry
Healthcare Economics and Policy
Applications in Healthcare
Business Analytics
Analytics Applications
Biography
Dr. Kathleen Iacocca is adept at explaining the complexities of the U.S. healthcare economy and pharmaceutical drug pricing system in a way that provides clarity and understanding for her audience. Her research primarily centers on the healthcare industry, with specific focus on supply chains and optimization. She also more generally completes research in operations and analytics.
Education (3)
Rutgers University: PhD
The University of Scranton: MBA
The University of Scranton: BS
Select Accomplishments (5)
Recipient, Emerald Literati Network Award for Excellence (professional)
2016 Selected by the editors of the International Journal of Quality & Reliability Management for the paper "Improving the Quality of Environmental Management: Impact on Shareholder Value."
Second Place, INFORMS Annual Case Competition (professional)
2015 Presented case at the INFORMS Annual Meeting in Philadelphia.
Recipient, Emerald Literati Network Award for Excellence (professional)
2014 Selected by the editors of the International Journal of Pharmaceutical and Healthcare Marketing for the paper "Resell Versus Direct Models in Brand Drug Distribution."
Recipient, Highly Commendable Paper Award (professional)
2013 Selected by the editors of the International Journal of Pharmaceutical and Healthcare Marketing for the paper "Resell Versus Direct Models in Brand Drug Distribution."
Recipient, "KSOM Professor of the Year" Award (professional)
2013 Determined by University of Scranton students.
Links (1)
Affiliations (4)
- Data Analytics, Statistics and Operations Consultant, Fortune 50 Company
- Member, Institute for Operations Research and Management Science (INFORMS)
- Member, Decision Sciences Institute (DSI)
- Member, The Association for Operations Management (APICS)
Select Media Appearances (5)
Amazon Delivery Drivers in Skokie, Six Other Facilities Go on Strike: "We're the Ones Who Move the Packages Every Day"
Chicago Tribune
2024-12-19
Kathleen Iacocca, a supply chain expert and associate professor at the Villanova School of Business, said the impact of the Amazon delivery strike may initially be limited to the immediate areas near the seven facilities where drivers have walked off the job... But if the strike gains traction and spreads to other Amazon facilities, with a large number of drivers joining the walkout, the company and its customers could begin to feel some pain in the weeks ahead. "Once we hit over a certain threshold, Amazon is going to start to sweat," Iacocca said.
How the Dockworker Strike Could Impact the Philadelphia Region
NBC 10
2024-10-01
With the first dockworker strike on the East Coast in almost 50 years now underway, experts and consumers in the Philadelphia area and beyond are preparing for the possible impact... Dr. Iacocca told NBC 10 that consumers won't feel the immediate impact, but prices will go up if the strike lasts longer than a month, especially for items like seafood, electronics, cars and medications.
Baltimore Bridge Collapse Raises Questions About Safety Around Philly-Area Bridges
6 ABC
2024-03-27
While Philadelphia may not be as vulnerable to a bridge collapse, its waterways will still feel the impacts from Baltimore. "Consumers are perhaps going to see that there's a delay in products," shared Villanova University's Kathleen Iacocca.
Guest View: The Healthcare Industry Is Sick. But Can It Afford to Get Better?
American Pharmacy News
2017-06-30
"Right now, President Trump and lawmakers in Washington are wrangling over the details of a proposed healthcare law that would 'repeal and replace' Obamacare. Through all of the rhetoric and political jockeying, it's important to remember that there is a huge industry in the middle of this fight. And that industry is in crisis."
Pharma Seeks Growth in Eyecare
Pharmaceutical Commerce
2016-11-07
In his final troubled days as Valeant's CEO last year, Michael Pearson struck a deal with Walgreens Boots Alliance for the pharmacy chain to sell certain ophthalmic and dermatologic drugs directly from its 8,000 U.S. locations on a consignment basis, skipping over wholesalers... For Valeant, the arrangement proved disastrous. It footed the bill for the 25% of prescriptions that payers refused to cover and saw its eye-drug sales plunge 30% in the first quarter of this year... "It's a shame to think of this as a failure, because I do think a model like this could work," says Kathleen Iacocca, PhD, an assistant professor at Villanova University School of Business, who has studied drug supply chains.
Select Academic Articles (4)
Why Brand Drugs Priced Higher Than Generic Equivalents
International Journal of Pharmaceutical and Healthcare MarketingKathleen Iacocca, James Sawhill, Yao Zhao
2015
The Point of Purchase Decision in a Supply Chain With Value-Added Reselling
International Journal of Production ResearchKingsley Gnanendran, Kathleen Iacocca
2015
Resell Versus Direct Models in Brand Drug Distribution
International Journal of Pharmaceutical and Healthcare MarketingKathleen Iacocca, Yao Zhao, Adam Fein
2013
A Multiple Regression Model to Explain the Cost of Brand-Drugs
Socio-Economic Planning SciencesKathleen Iacocca, James Sawhill, Yao Zhao
2012
Social